Nice endorses radiosurgery treatments for trigeminal neuralgia, supporting accuray cyberknife® system indications for use

Sunnyvale, calif., feb. 28, 2022 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that the national institute for health and care excellence (nice)* has endorsed the use of radiosurgery for trigeminal neuralgia (tn), strengthening the evidence for the company to market its cyberknife® treatment delivery system for this indication in the united kingdom.
ARAY Ratings Summary
ARAY Quant Ranking